Abstract | OBJECTIVES: METHODS: RESULTS: Plasma human papillomavirus 16 DNA was detected in only 30.0% of the patients with human papillomavirus 16-positive cervical cancer and in none of normal controls. The copy number of plasma human papillomavirus 16 DNA was higher in patients with invasive cancer than in those with cervical intraepithelial neoplasia (CIN3), micro-invasive cancer and in normal individuals. CONCLUSIONS:
|
Authors | Takako Shimada, Naohiro Yamaguchi, Noriyuki Nishida, Kentaro Yamasaki, Kiyonori Miura, Shigeru Katamine, Hideaki Masuzaki |
Journal | Japanese journal of clinical oncology
(Jpn J Clin Oncol)
Vol. 40
Issue 5
Pg. 420-4
(May 2010)
ISSN: 1465-3621 [Electronic] England |
PMID | 20133337
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antigens, Neoplasm
- Biomarkers, Tumor
- DNA, Viral
- Serpins
- squamous cell carcinoma-related antigen
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Antigens, Neoplasm
(blood)
- Biomarkers, Tumor
(blood)
- Case-Control Studies
- DNA, Viral
(blood)
- Early Diagnosis
- Female
- Human papillomavirus 16
(genetics)
- Humans
- Japan
(epidemiology)
- Middle Aged
- Sensitivity and Specificity
- Seroepidemiologic Studies
- Serpins
(blood)
- Uterine Cervical Neoplasms
(blood, diagnosis, epidemiology)
- Uterine Cervical Dysplasia
(diagnosis, epidemiology, genetics)
|